Have a personal or library account? Click to login
Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn Cover

Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn

Immunohematology
Volume 33 (2017): Issue 4 (December 2017)
By: K.J. Moise,  Y. Morales,  M.F. Bertholf,  S.N. Rossmann and  Y. Bai  
Paid access
|Oct 2019

Authors

K.J. Moise

Kenneth.J.Moise@uth.tmc.edu

Department of Obstetrics, Gynecology, Reproductive Sciences, The McGovern School of Medicine at the University of Texas Health Science Center, the Fetal Center at Children’s Memorial Hermann Hospital, Houston, TX, United States

Y. Morales

Department of Obstetrics, Gynecology, Reproductive Sciences, The McGovern School of Medicine at the University of Texas Health Science Center, Fetal Center at Children’s Memorial Hermann Hospital, Houston, TX, United States

M.F. Bertholf

Medical Services, Gulf Coast Regional Blood Center, Houston, TX, United States

S.N. Rossmann

Gulf Coast Regional Blood Center, Houston, TX, United States

Y. Bai

The Department of Pathology and Laboratory Medicine, The McGovern School of Medicine at the University of Texas Health Science Center, Houston, TX, United States
DOI: https://doi.org/10.21307/immunohematology-2019-021 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 152 - 154
Published on: Oct 16, 2019
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
anti-Vel,
Vel,
red blood cell antibody,
red blood cell alloimmunization,
hemolytic disease of the fetus and newborn,
intrauterine transfusion
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2019 K.J. Moise, Y. Morales, M.F. Bertholf, S.N. Rossmann, Y. Bai, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 33 (2017): Issue 4 (December 2017)Next article